DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Tesis de maestría (MasterThesis)
Neuroprotective mechanisms of resveratrol in a high-fat diet-fed Alzheimer's disease mouse model
Over the last decades there has been an over consumption of foods rich in animal fats that has led to a
global obesity pandemic. Obesity presents itself with a number of comorbidities, including an increased
risk for the development of neurodegenerative disorders such as Alzheimer’s disease (AD). On the other
hand, reducing caloric intake has showed to delay age-related diseases and resveratrol, a polyphenol
produced by a variety of plants, has emerged as a potent mimetic of this caloric restriction. The
mechanisms underlying both effects are not fully understood and, as potential therapeutic targets, need
to be thoroughly analyzed. To this end, we have analyzed molecular pathways involved in memory loss
in mice as a result of a high-fat diet (HFD) administration and the role that resveratrol supplementation
on this diet may play. We have focused on 6-months-old 5xFAD mice, which are transgenic AD mice with
a high amyloid burden, and wild type (WT) mice. Both mice strains fed with HFD showed impairment of
recognition memory but when resveratrol was added to the HFD, recognition memory was restored.
Moreover, our results indicate that HFD boosts amyloid pathology in both, WT and 5xFAD mice, mainly
through the potentiation of the amyloidogenic pathway and the reduction of the non-amyloidogenic
one. Namely, we identified an increase in β-secretase (BACE1) protein levels in both strains and a
decrease in α-secretase (ADAM10) expression in WT mice after HFD administration. Tau pathology was
as well aggravated in both strains. Interestingly, HFD has showed the capacity to enhance the activity of
the ubiquitin-proteasome system, being the most significant changes the induction of proteasome
caspase-like and chymotrypsin-like activities. Remarkably, resveratrol has demonstrated the capability
to normalize all the pathological changes induced by the HFD in both WT and 5xFAD mice, confirming its
preventive and therapeutic potential against neurodegeneration., SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and
the European Regional Development Fund (ERDF); AGAUR 2017-SGR-106 and the
CERCA Programme of the Generalitat de Catalunya; R. Copas and C. Sanfeliu belong
to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de
Salud Carlos III, Ministerio de Sanidad y Consumo, Spain, Peer reviewed